A prominently published study reported an improvement in mortality in acute respiratory distress syndrome (ARDS) patients who received early treatment with the paralyzing agent cisatracurium. [1] ...
Researchers at Endeavor Health and Northwestern University have created an artificial intelligence-based tool to help doctors recognize an underdiagnosed, often fatal respiratory syndrome found in ...
Basophils, a type of white blood cell, promote recovery from acute respiratory distress syndrome (ARDS) in mice, according to researchers at Science Tokyo. In a mouse model of ARDS, basophils were ...
A novel peptide designed by University of California, Irvine researchers has been found to suppress the damaging lung inflammation seen in acute respiratory distress syndrome, or ARDS. Their study, ...
The National Academies of Sciences, Engineering, and Medicine are private, nonprofit institutions that provide expert advice on some of the most pressing challenges facing the nation and world. Our ...
Passive immunization with plasma collected from convalescent patients has been regularly used to treat coronavirus disease 2019 (Covid-19). Minimal data are available regarding the use of convalescent ...
NEWTOWN, Pa.--(BUSINESS WIRE)--Biomarck Pharmaceuticals, Ltd., a clinical-stage biopharmaceutical company focused on developing peptides that inhibit MARCKS to treat patients with inflammatory ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback